BNP in mitral valve restrictive annuloplasty for ischemic mitral regurgitation

International Journal of Cardiology

Volumn 137, Issue 1, 2009, Pages 57-60

  Paparella, Domenico ^a   Malvindi, Pietro Giorgio ^a   Romito, Roberta ^b   Iacoviello, Massimo ^a   Visicchio, Giuseppe ^a   Di Serio, Francesca ^b   Favale, Stefano ^a   de Luca Tupputi Schinosa, Luigi ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Brain natriuretic peptide; Congestive heart failure; Coronary disease; Functional mitral regurgitation; Myocardial infarction; Valve disease

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; PATIENT SAFETY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SURGICAL MORTALITY;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN;

EID: 68949132851     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.090     Document Type: Article

References (13)

1. Grigioni F., Enriquez-Sarano M., Zehr K.J., Bailey K.R., and Tajik A.J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative doppler assessment. Circulation 103 (2001) 1759-1764
2. Sutton T.M., Stewart R.A., Gerber I.L., West T.M., et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 41 (2003) 2280-2287
3. Detaint D., Messika-Zeitoun D., Chen H.H., et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol 97 (2006) 1029-1034
4. Hartmann F., Packer M., Coats A.j., et al. Prognostic Impact of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure A Substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial. Circulation 110 (2004) 1780-1786
5. Paparella D., Mickleborough L.L., Carson S., and Ivanov J. Mild to moderate mitral regurgitation in patients undergoing coronary bypass grafting: effects on operative mortality and long-term significance. Ann Thorac Surg 76 (2003) 1094-1100
6. Bax J.J., Braun J., Somer S.T., et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110 11 suppl I (2004) II103-II108
7. Geidel S., Lass M., Schneider, et al. Downsizing of the mitral valve and coronary revascularization in severe ischemic mitral regurgitation results in reverse left ventricular and left atrial remodeling. Eur J Cardio-thorac Surg 27 (2005) 1011-1016
8. Tibayan F.A., Rodriguez F., Langer F., et al. Annular or subvalvular approach to chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 129 (2005) 1266-1275
9. Bolling S.F., Pagani F.D., Deeb G.M., and Bach D.S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115 (1998) 381-388
10. Diodato M.O., Moon M.R., Pasque M.K., et al. Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg 78 (2004) 794-799
11. Mihaljevic T., Lam B.K., Rajeswaran J., et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49 (2007) 2191-2201
12. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
13. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516